Browsing by Author "Bilge, İlmay"
Now showing items 1-2 of 2
-
COVID-19 in pediatric nephrology centers in Turkey
Leventoğlu, Emre; Özdemir Atikel, Yeşim; Nalçacıoğlu, Hülya; Dursun, İsmail; Dursun, Hasan; Yürük Yıldırım, Zeynep; Yıldız, Nurdan; Kaya Aksoy, Gülşah; Taşdemir, Mehmet; Çelakil, Mehtap; Demircioğlu Kılıç, Beltinge; Zırhlı Selçuk, Şena; Canpolat, Nur; Kargın Çakıcı, Evrim; Özlü, Sare Gülfem; Tülpar, Sebahat; Yüksel, Selçuk; Atmış, Bahriye; Sürmeli Döven, Serra; Taner, Sevgin; Ertan, Pelin; Kavaz, Aslı; Torun Bayram, Meral; Kalyoncu, Mukaddes; Gülleroğlu, Kaan; Kabasakal, Caner; Kasap Demir, Belde; Çiçek, Rümeysa Yasemin; Bilge, İlmay; Dönmez, Osman; Kara, Aslıhan; Yavaşcan, Önder; Özçelik, Gül; Gezgin Yıldırım, Deniz; Güler, Muhammet Akif; Sönmez, Ferah; Poyrazoğlu, Hakan; Akman, Sema; Topaloğlu, Rezan; Alpay, Harika; Bakkaloğlu, Sevcan Azime (Turkiye Klinikleri, 2022)Background/aim: There is limited data on COVID-19 disease in children with kidney disease. We aimed to investigate the characteristics and prognosis of COVID-19 in pediatric nephrology patients in Turkey. Materials and ... -
Rituximab treatment for difficult-to-treat nephrotic syndrome in children: A multicenter, retrospective study
Taşdemir, Mehmet; Canpolat, Nur; Yıldız, Nurdan; Özçelik, Gül; Benzer, Meryem; Saygılı, Seha Kamil; Özkayın, Emine Neşe; Türkkan, Özde Nisa; Balat, Ayşe; Candan, Cengiz; Çelakıl, Mehtap; Yavuz, Sevgi; Akıncı, Nurver; Göknar, Nilüfer; Akgün, Cihangir; Tülpar, Sebahat; Alpay, Harika; Sever, Fatma Lale; Bilge, İlmay (TÜBİTAK Scientific and Technological Research Council of Turkey, 2021)Background/aim: This study aimed to evaluate the efficacy of rituximab in children with difficult-to-treat nephrotic syndrome, considering the type of disease (steroid-sensitive or -resistant) and the dosing regimen. Materials ...
